{
    "eid": "2-s2.0-84962016521",
    "title": "Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis",
    "cover-date": "2016-05-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Virology",
            "@code": "2406"
        }
    ],
    "keywords": [
        "Genotype 6",
        "Hepatitis C virus",
        "Host factors",
        "Meta-analysis",
        "Pegylated interferon",
        "Ribavirin",
        "Viral factors"
    ],
    "authors": [
        "Vo Duy Thong"
    ],
    "citedby-count": 6,
    "ref-count": 34,
    "ref-list": [
        "Evolving epidemiology of hepatitis C virus",
        "The burden of hepatitis C in the United States",
        "Hepatitis C virus genotype 6: Virology, epidemiology, genetic variation and clinical implication",
        "Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection",
        "Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial",
        "Hepatitis C virus: Virology, diagnosis and management of antiviral therapy",
        "Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6",
        "Response to pegylated interferon and ribavirin in Asian American patients with Chronic hepatitis C genotypes 1 vs 2/3 vs 6",
        "Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong",
        "Gastroenterol Hepa-tol (NY)",
        "Meta-analysis: Influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin",
        "Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement",
        "Cochrane handbook for systematic reviews of interventions",
        "An Introduction to Stata for Health Researchers, Ed 2",
        "Data Analysis Using Sta-ta, Ed 2",
        "Graphical Tools for Network Meta-Analysis in STATA",
        "Hepatology",
        "Twenty-four weeks of pegylated interferon plus ribavirin effectively treat patients with HCV genotype 6a",
        "Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1",
        "A randomized trial of 48 versus 24 weeks of combination pegylated interferon and ribavirin therapy in genotype 6 chronic hepatitis C",
        "Response-guided therapy for patients with hepatitis C virus genotype 6 infection: A pilot study",
        "J Hepatol",
        "Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection",
        "Higher rate of sustained virologic response in chronic hepatitis c genotype 6 treated with 48 weeks versus 24 weeks of peginterferon plus ribavirin",
        "Treatment results of chronic hepatitis C genotype 5 and 6 infections in Germany",
        "Randomized controlled trial of pegylated interferon-alfa 2a and ribavirin in treatment-naive chronic hepatitis C genotype 6",
        "Chronic hepatitis C virus genotype 6 infection: Response to pegylated interferon and ribavirin",
        "Hepatology",
        "IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6",
        "Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans",
        "Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: A meta-analysis",
        "Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202)",
        "Sofosbuvir for previously untreated chronic hepatitis C infection",
        "Diagnosis, management, and treatment of hepatitis C: An update"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Ho Chi Minh City",
            "affilname": "University of Medicine and Pharmacy at HCMC",
            "affiliation-country": "Viet Nam"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "affilname": "Mahidol University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Research University Project",
        "Office of the Higher Education Commission",
        "Office of the Higher Education Commission",
        "National Science and Technology Development Agency",
        "National Research Council of Thailand"
    ]
}